Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk.

Barrett TJ, Murphy AJ, Goldberg IJ, Fisher EA.

Ann N Y Acad Sci. 2017 Aug;1402(1):31-42. doi: 10.1111/nyas.13462. Review.

PMID:
28926114
2.

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.

Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M.

PLoS One. 2017 Jul 28;12(7):e0182359. doi: 10.1371/journal.pone.0182359. eCollection 2017.

3.

ASSOCIATION OF TOTAL AND DIFFERENTIAL WHITE BLOOD CELL COUNTS TO DEVELOPMENT OF TYPE 2 DIABETES IN MEXICAN AMERICANS IN CAMERON COUNTY HISPANIC COHORT.

Vatcheva KP, Fisher-Hoch SP, Rahbar MH, Lee M, Olvera RL, Mccormick JB.

Diabetes Res. 2015 Sep;1(4):103-112. doi: 10.17140/DROJ-1-117. Epub 2015 Sep 23.

4.

Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.

Goldfine AB, Shoelson SE.

J Clin Invest. 2017 Jan 3;127(1):83-93. doi: 10.1172/JCI88884. Epub 2017 Jan 3. Review.

5.

Acute-phase proteins and incidence of diabetes: a population-based cohort study.

Muhammad IF, Borné Y, Hedblad B, Nilsson PM, Persson M, Engström G.

Acta Diabetol. 2016 Dec;53(6):981-989. doi: 10.1007/s00592-016-0903-8. Epub 2016 Aug 31.

6.

Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis.

Kraakman MJ, Dragoljevic D, Kammoun HL, Murphy AJ.

Clin Transl Immunology. 2016 May 20;5(5):e84. doi: 10.1038/cti.2016.31. eCollection 2016 May. Review.

7.
8.

Total and Differential Leukocyte Counts in Relation to Incidence of Diabetes Mellitus: A Prospective Population-Based Cohort Study.

Borné Y, Smith JG, Nilsson PM, Melander O, Hedblad B, Engström G.

PLoS One. 2016 Feb 18;11(2):e0148963. doi: 10.1371/journal.pone.0148963. eCollection 2016.

9.

Disordered haematopoiesis and athero-thrombosis.

Murphy AJ, Tall AR.

Eur Heart J. 2016 Apr 7;37(14):1113-21. doi: 10.1093/eurheartj/ehv718. Epub 2016 Feb 10. Review.

10.

Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer.

Jeon HJ, Kim JM, Cho CK, Lee YW, Yoo HS.

J Pharmacopuncture. 2015 Sep;18(3):19-31. doi: 10.3831/KPI.2015.18.021.

11.

Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease.

Park CS, Chung WB, Choi YS, Kim PJ, Lee JM, Baek KH, Kim HY, Yoo KD, Song KH, Chung WS, Seung KB, Lee MY, Kwon HS.

PLoS One. 2015 Aug 21;10(8):e0136354. doi: 10.1371/journal.pone.0136354. eCollection 2015.

12.

Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity?

Heinecke JW, Goldberg IJ.

Diabetes. 2014 Dec;63(12):4001-3. doi: 10.2337/db14-1273. No abstract available.

13.

miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.

Distel E, Barrett TJ, Chung K, Girgis NM, Parathath S, Essau CC, Murphy AJ, Moore KJ, Fisher EA.

Circ Res. 2014 Oct 10;115(9):759-69. doi: 10.1161/CIRCRESAHA.115.304164. Epub 2014 Sep 8.

14.

Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity.

Nagareddy PR, Kraakman M, Masters SL, Stirzaker RA, Gorman DJ, Grant RW, Dragoljevic D, Hong ES, Abdel-Latif A, Smyth SS, Choi SH, Korner J, Bornfeldt KE, Fisher EA, Dixit VD, Tall AR, Goldberg IJ, Murphy AJ.

Cell Metab. 2014 May 6;19(5):821-35. doi: 10.1016/j.cmet.2014.03.029.

15.

Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.

Lee BC, Lee J.

Biochim Biophys Acta. 2014 Mar;1842(3):446-62. doi: 10.1016/j.bbadis.2013.05.017. Epub 2013 May 22. Review.

16.

Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, Ramkhelawon B, Distel E, Westerterp M, Huang LS, Schmidt AM, Orchard TJ, Fisher EA, Tall AR, Goldberg IJ.

Cell Metab. 2013 May 7;17(5):695-708. doi: 10.1016/j.cmet.2013.04.001.

17.

The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults.

Jung CH, Lee WY, Kim BY, Park SE, Rhee EJ, Park CY, Oh KW, Mok JO, Kim CH, Park SW, Kim SW, Kang SK.

Yonsei Med J. 2013 May 1;54(3):615-20. doi: 10.3349/ymj.2013.54.3.615.

18.

Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes.

Lee J.

Arch Pharm Res. 2013 Feb;36(2):208-22. doi: 10.1007/s12272-013-0023-8. Epub 2013 Feb 10. Review.

19.

Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.

Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, Chen LK, Gokulakrishnan K, Hanefeld M, Ingelsson E, Lai WA, Lin SY, Lind L, Lohsoonthorn V, Mohan V, Muscari A, Nilsson G, Ohrvik J, Chao Qiang J, Jenny NS, Tamakoshi K, Temelkova-Kurktschiev T, Wang YY, Yajnik CS, Zoli M, Khaw KT, Forouhi NG, Wareham NJ, Langenberg C.

PLoS One. 2010 Oct 18;5(10):e13405. doi: 10.1371/journal.pone.0013405. Review.

20.

The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study.

Chao C, Song Y, Cook N, Tseng CH, Manson JE, Eaton C, Margolis KL, Rodriguez B, Phillips LS, Tinker LF, Liu S.

Arch Intern Med. 2010 Sep 27;170(17):1557-65. doi: 10.1001/archinternmed.2010.312.

Supplemental Content

Support Center